Top Banner
Presented by T.SHIVAKUMAR KOTTAM INSTITUTE OF PHARMACY Self micro emulsified drug delivery system
23
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Smedds seminaaar final

Presented byT.SHIVAKUMAR

KOTTAM INSTITUTE OF PHARMACY

Self micro emulsified drug delivery

system

Page 2: Smedds seminaaar final

WHAT IS SMEDDSSMEEDS is mixture of oils, surfactants, and cosurfactants, which are emulsified in aqueous media under conditions of gentle agitation of digestive motility that would be encountered in the gastro intestinal (GI) tract.

Page 3: Smedds seminaaar final

AIMMost of the new drug candidates in development today are sparingly soluble and associated with poor bioavailability

The main purpose is to prepare SMEDDS for oral bioavailability enhancement of a poorly water soluble drug

Page 4: Smedds seminaaar final

Bio pharmaceutical classification system

Page 5: Smedds seminaaar final

according to bio pharmaceutical classification system(BCS) the classII drugs have poor solubility and high permeability , thus the rate limiting process of absorption is the drug dissolution step. Formulation plays the major role in improving the rate and extent of absorption of such drugs from GI tract.

Page 6: Smedds seminaaar final

Present studyIn the present study, an attempt was made to enhance the solubility and in vitro dissolution of candesartan cilexetil byformulating it as SMEDDS for filling into hard gelatin capsules.

Page 7: Smedds seminaaar final

Drug profileCandesartan Cilexetil a prodrug is hydrolyzed to candesartan during absorption from the gastrointestinal tract., practically insoluble in water.

Category: Antihypertensive Agents

Subcategory: Angiotensin II Receptor Antagonist

Page 8: Smedds seminaaar final

Structure

Page 9: Smedds seminaaar final

Materials

Drug- Candesartan cilexetile-Oil -Miglyol 812Surfactants- Cremophor EL

&Tween 80Cosurfactant -Labrasol

Page 10: Smedds seminaaar final

The quantity of each content will be taken according to the pseudo ternary phase diagram

This diagram is very essential in manipulation of ingredients in the formulation of SMEDDS

Page 11: Smedds seminaaar final

CONSTRUCTION OF PSUEDO TERNARY PHASE DIAGRAMS:

The pseudoternary phase diagrams of oil, surfactant– cosurfactant, and water were developed to optimize

the formulation using a water titration method. The

mixtures of oil and surfactant–cosurfactant ratios were diluted

with water in a dropwise addition. Phase diagrams were

constructed in the presence of drug to obtain the optimum

concentrations of oil, surfactant, and cosurfactant. SMEDDS form fine

oil– water emulsions upon addition to an aqueous media

under gentle agitation.

Page 12: Smedds seminaaar final

Pseudo ternary phase diagram

The gray area indicates the microemulsion region

Page 13: Smedds seminaaar final

formulation Four self-microemulsifying formulations

were prepared using mixtures of oils, surfactants, and cosurfactants in various proportions. The self-microemulsification properties, droplet size, and zeta potential of these formulations were studied upon dilution with water. The optimized liquid SMEDDS formulation was converted into free flowing powder by adsorbing onto a solid carrier for encapsulation.

Page 14: Smedds seminaaar final
Page 15: Smedds seminaaar final

images of pure drug substance (left), solid SMEDDS (right; magnification

Page 16: Smedds seminaaar final

Dissolution studies

The dissolution characteristics of solid intermediates of SMEDDS filled into hard gelatin capsules was investigated and compared with liquid formulation and commercial formulation to ascertain the impact on self-emulsifying properties following conversion.

Page 17: Smedds seminaaar final

ResultsThe results indicated that solid intermediates

showed comparable rate and extent of drug dissolution in a discriminating dissolution medium as liquid SMEDDS indicating that the self-emulsifying properties of SMEDDS were unaffected following conversion. Also, the rate and extent of drug dissolution for solid intermediates was significantly higher than commercial tablet formulation. The results from this study demonstrate the potential use of SMEDDS as a means of improving solubility, dissolution, and concomitantly the bioavailability. 

Page 18: Smedds seminaaar final

Comparision of dissolution studies

Page 19: Smedds seminaaar final

Advantages Protection of sensitive drug substances.The emulsion droplets will deliver the drug to GI

mucosa in dissolved state readily accessible for absorption

When a polymer is incorporated in terms of SMEDDS it gives prolonged release of medicament

They are comprised of aqueous and oily components and therfore can accommodate both hydrophilic aswell as lipophylic drugs

Page 20: Smedds seminaaar final

Disadvantages

Chemical instabilities Irritates GIT Precipitation of the lipophilic drugs Physical and chemical changes in

crystalline solid in Cryogenic grinding

Page 21: Smedds seminaaar final

CONCLUSION

A SMEDDS formulation of a poorly water-soluble drug, candesartan cilexetil was formulated for direct filling into hardgelatin capsules for oral administrationshowed faster rate of drug release than the marketed product in

a discriminating dissolution media. The results from this study

demonstrate the utility of SMEDDS to enhance solubility and

dissolution of sparingly soluble compounds like candesartan

which may result in improved therapeutic performance

Page 22: Smedds seminaaar final

REFERENCES1. Robinson JR. Introduction: semi-solid formulations for

oral drug delivery. Bull Tech Gattefosse. 1996;89:11–32. Aungst BJ. Novel formulation strategies for improving

oral bioavailability of drugs with poor membrane

permeation or presystemic metabolism. J Pharm Sci. 1993;82:979–87.3. Constantinides PP. Lipid microemulsions for improving

drug dissolution and oral absorption: physical and

biopharmaceutical aspects. Pharm Res. 1995;12:1561–72.4. Pouton CW. Formulation of self-emulsifying drug

delivery systems.

Page 23: Smedds seminaaar final

Thank you….